Trial Profile
A Phase 1 Study To Assess the Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Nov 2011
Price :
$35
*
At a glance
- Drugs Linifanib (Primary) ; Rifampicin
- Indications Bacterial infections; Solid tumours
- Focus Pharmacokinetics
- 01 Nov 2011 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
- 01 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Jul 2011 New trial record